Enzalutamide-Resistant Progression of Castration-Resistant Prostate Cancer Is Driven via the JAK2/STAT1-Dependent Pathway

Previous studies showed that CXCR7 expression was upregulated after enzalutamide (ENZ) treatment, and an increased level of CXCR7 could increase the invasion, migration, and angiogenesis of castration-resistant prostate cancer (CRPC) cells. This study demonstrated that the levels of p-JAK2, p-STAT1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yong, Yang, Xiaobing, Basourakos, Spyridon P., Zuo, Xuemei, Wei, Dechao, Zhao, Jiahui, Li, Mingchuan, Li, Qiankun, Feng, Tao, Guo, Pengju, Jiang, Yongguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570343/
https://www.ncbi.nlm.nih.gov/pubmed/34746227
http://dx.doi.org/10.3389/fmolb.2021.652443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570343/
https://www.ncbi.nlm.nih.gov/pubmed/34746227
http://dx.doi.org/10.3389/fmolb.2021.652443

Ejemplares similares